pharmaphorum

JANUARY 27, 2022

The inaugural LNP Formulation & Process Development Summit is the industry’s first forum dedicated to bringing together drug developers within the LNP field to share the latest scientific breakthroughs on formulation and process development. billion by 2027.

Vaccines 52

Vaccines Drug Development 52

FDA Law Blog: Biosimilars

AUGUST 23, 2023

FDA has made good progress on these initial goals, providing updates on the first four on the Digital Health Technologies (DHTs) for Drug Development website. Earlier this year, FDA published the Framework for the Use of Digital Health Technologies in Drug and Biological Product Development (DHT Framework).

Drug Development 52

Drug Development Documentation 52

Syner-G

JULY 7, 2023

Cell and gene therapies have been subjects of research for some time, but they have gained traction in real-world medicine and are projected to reach a market value of more than $36 billion by 2027. Drug development companies must embrace new technology. Efficient clinical and commercial manufacturing presents issues, too.

Medical Records 52

Medical Records Drug Development Dosage 52

European Pharmaceutical Review

MARCH 4, 2024

Indeed, in 2022, biologics constituted 40 percent of all US Food and Drug Administration (FDA) approved drugs, projecting a compound annual growth rate (CAGR) of 9.5 percent through 2027. Anna has a medical degree and a postgraduate degree in healthcare management and is an expert in all stages of drug development.

Vaccines 98

Vaccines Immunity Immunization Compounding 98

pharmaphorum

JANUARY 18, 2022

million in 2020 and with the rapid growth of the industry, is expected to grow at a CAGR of 8.95% up to 2027. Smart device developers. Training device developers. Drug developers. Device innovations, connected delivery and regulatory guidance for advanced parenteral systems. Medical Device Engineers.

Packaging 52

Packaging Documentation Vaccines Drug Development 52

European Pharmaceutical Review

FEBRUARY 7, 2023

of the MDR and Article 110.4 of the IVDR for medical devices and in vitro diagnostic medical devices (IVDs).

Packaging 117

Packaging Drug Development 117

Putting Patients First Blog

AUGUST 2, 2023

MACC Commissioner United States Food and Drug Administration 5630 Fishers Lane, Rm. In our comments on the final patient-focused drug development guidance, the NHC referenced the need to create a connection between other trial guidances, such as this one and the PFDD guidance3. Califf M.D.,

Hospitals 40

Hospitals Drug Development 40

Putting Patients First Blog

APRIL 14, 2023

Driven by the work of the Food and Drug Administration on patient-focused drug development (PFDD), many companies in the biopharmaceutical community have devoted significant resources to better understand patient populations and are working to bring to market products that best suit their needs. Sincerely, Randall L.

Drug Pricing 40

Drug Pricing Drug Development Documentation Communication 40

STAT

FEBRUARY 21, 2025

per share in a contingent value right, or CVR, if Bluebird’s portfolio of therapies start to become commercially successful, bringing in at least $600 million per year by 2027. Bluebird shareholders will receive around $3 per share but can obtain another $6.87 The company had entered Friday with a market cap of $68.4

Drug Development 353

Drug Development 353

Pharmaceutical Technology

APRIL 24, 2023

GlobalData predicts that Comirnaty’s sales will increase by more than 20% between 2024 and 2027. Using nanomedicine to overcome drug delivery barriers Apart from lipid nanoparticles, nanoparticle-related innovation is also reaching other types of drug development.

Vaccines 59

Vaccines Immunity Immunization Medical Schools 59

Pharmaceutical Technology

JUNE 21, 2023

Life sciences venture capital firm Flagship Pioneering has unveiled Empress Therapeutics, a small molecule drug development startup. This will support development of its proprietary Chemilogics platform and drug discovery pipeline. So far, Empress claims to have generated 15 drug leads across multiple indications.

Compounding 52

Compounding Communication Immunity Immunization 52

Pharmaceutical Technology

NOVEMBER 30, 2022

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. According to GlobalData, as of November 28, there were 316 generic and novel drugs marketed to treat obesity. Anti-obesity therapeutic landscape.

Insurance Coverage and Processing 105

Insurance Coverage and Processing Diabetes Labelling Communication 105

Pharmaceutical Technology

NOVEMBER 30, 2022

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. According to GlobalData, as of November 28, there were 316 generic and novel drugs marketed to treat obesity. Anti-obesity therapeutic landscape.

Insurance Coverage and Processing 98

Insurance Coverage and Processing Diabetes Labelling Communication 98

Drug Patent Watch

JANUARY 6, 2025

The biopharmaceutical industry is witnessing unprecedented growth, with the Contract Development and Manufacturing Organization (CDMO) market expected to reach $289.64 billion by 2027. This article explores the key strategies for ensuring that CDMO services are tailored to meet the strategic objectives of biopharmaceutical companies.

Communication 52

Communication Drug Development 52